1. Home
  2. VCYT vs NMIH Comparison

VCYT vs NMIH Comparison

Compare VCYT & NMIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCYT
  • NMIH
  • Stock Information
  • Founded
  • VCYT 2006
  • NMIH 2011
  • Country
  • VCYT United States
  • NMIH United States
  • Employees
  • VCYT N/A
  • NMIH N/A
  • Industry
  • VCYT Medical Specialities
  • NMIH Property-Casualty Insurers
  • Sector
  • VCYT Health Care
  • NMIH Finance
  • Exchange
  • VCYT Nasdaq
  • NMIH Nasdaq
  • Market Cap
  • VCYT 2.9B
  • NMIH 2.8B
  • IPO Year
  • VCYT 2013
  • NMIH 2013
  • Fundamental
  • Price
  • VCYT $41.51
  • NMIH $36.67
  • Analyst Decision
  • VCYT Buy
  • NMIH Buy
  • Analyst Count
  • VCYT 10
  • NMIH 6
  • Target Price
  • VCYT $42.40
  • NMIH $42.17
  • AVG Volume (30 Days)
  • VCYT 1.0M
  • NMIH 396.9K
  • Earning Date
  • VCYT 11-04-2025
  • NMIH 11-04-2025
  • Dividend Yield
  • VCYT N/A
  • NMIH N/A
  • EPS Growth
  • VCYT N/A
  • NMIH 9.56
  • EPS
  • VCYT 0.38
  • NMIH 4.79
  • Revenue
  • VCYT $495,141,000.00
  • NMIH $692,208,000.00
  • Revenue This Year
  • VCYT $14.52
  • NMIH N/A
  • Revenue Next Year
  • VCYT $9.90
  • NMIH $5.15
  • P/E Ratio
  • VCYT $109.62
  • NMIH $7.63
  • Revenue Growth
  • VCYT 16.41
  • NMIH 8.86
  • 52 Week Low
  • VCYT $22.61
  • NMIH $31.90
  • 52 Week High
  • VCYT $47.32
  • NMIH $43.20
  • Technical
  • Relative Strength Index (RSI)
  • VCYT 63.38
  • NMIH 49.12
  • Support Level
  • VCYT $35.27
  • NMIH $34.84
  • Resistance Level
  • VCYT $46.41
  • NMIH $37.37
  • Average True Range (ATR)
  • VCYT 1.92
  • NMIH 0.93
  • MACD
  • VCYT 0.62
  • NMIH 0.14
  • Stochastic Oscillator
  • VCYT 59.02
  • NMIH 69.85

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

About NMIH NMI Holdings Inc.

NMI Holdings Inc through its subsidiaries provides private mortgage guaranty insurance. The company offers mortgage insurance, reinsurance on loans, and outsourced loan review services to mortgage loan originators. It serves national and regional mortgage banks, money center banks, credit unions, community banks, builder-owned mortgage lenders, Internet-sourced lenders, and other non-bank lenders. It protects lenders and investors from default-related losses on a portion of the unpaid principal balance of a covered mortgage.

Share on Social Networks: